Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;1.133
Companies that carry out R&D in Biotechnology;Main;564
Companies that carry out R&D in Biotechnology;Secondary dwellings;212
Companies that carry out R&D in Biotechnology;Tool;358
%Companies according to biotechnology used: Genetic code;Total;32
%Companies according to biotechnology used: Genetic code;Main;42
%Companies according to biotechnology used: Genetic code;Secondary dwellings;22
%Companies according to biotechnology used: Genetic code;Tool;20
%Companies according to biotechnology used: Functional units;Total;41
%Companies according to biotechnology used: Functional units;Main;48
%Companies according to biotechnology used: Functional units;Secondary dwellings;40
%Companies according to biotechnology used: Functional units;Tool;30
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;27
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;33
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;24
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;19
%Companies according to biotechnology used: Bioprocesses;Total;48
%Companies according to biotechnology used: Bioprocesses;Main;41
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;47
%Companies according to biotechnology used: Bioprocesses;Tool;60
%Companies according to biotechnology used: Sub-cellular organisms;Total;8
%Companies according to biotechnology used: Sub-cellular organisms;Main;11
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;8
%Companies according to biotechnology used: Sub-cellular organisms;Tool;4
%Companies according to biotechnology used: Bio-computing;Total;21
%Companies according to biotechnology used: Bio-computing;Main;31
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;13
%Companies according to biotechnology used: Bio-computing;Tool;11
%Companies according to biotechnology used: Nanobiotechnology;Total;14
%Companies according to biotechnology used: Nanobiotechnology;Main;18
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;16
%Companies according to biotechnology used: Nanobiotechnology;Tool;7
%Companies according to biotechnology used: Other;Total;13
%Companies according to biotechnology used: Other;Main;13
%Companies according to biotechnology used: Other;Secondary dwellings;15
%Companies according to biotechnology used: Other;Tool;12
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;50
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;70
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;42
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;23
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;19
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;18
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;17
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;29
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;22
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;30
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;40
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;21
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;19
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;25
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;23
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;13
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;11
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;20
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;10
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;13
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;13
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;18
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;12
Personnel in R&D in biotechnology (no. of persons);Total;10.706
Personnel in R&D in biotechnology (no. of persons);Main;5.968
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1.806
Personnel in R&D in biotechnology (no. of persons);Tool;2.932
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;6.227
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;3.765
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;994
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;1.467
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;4.479
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;2.202
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;812
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;1.464
Personnel in R&D in biotechnology (no. of persons): women;Total;5.795
Personnel in R&D in biotechnology (no. of persons): women;Main;3.402
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;884
Personnel in R&D in biotechnology (no. of persons): women;Tool;1.510
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;3.269
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;2.049
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;503
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;717
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;2.527
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;1.353
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;381
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;793
Personnel in R&D in biotechnology (FTE);Total;7.716,4
Personnel in R&D in biotechnology (FTE);Main;4.708,3
Personnel in R&D in biotechnology (FTE);Secondary dwellings;1.165,8
Personnel in R&D in biotechnology (FTE);Tool;1.842,3
Personnel in R&D in biotechnology (FTE): Researchers;Total;4.603,1
Personnel in R&D in biotechnology (FTE): Researchers;Main;2.952,5
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;690,5
Personnel in R&D in biotechnology (FTE): Researchers;Tool;960,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;3.113,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;1.755,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;475,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;882,2
Personnel in R&D in biotechnology (FTE): women;Total;4.292,9
Personnel in R&D in biotechnology (FTE): women;Main;2.666
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;584,9
Personnel in R&D in biotechnology (FTE): women;Tool;1.042
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;2.446,4
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;1.592,2
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;352,1
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;502,1
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;1.846,5
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;1.073,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;232,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;539,9
Internal expenditure on R&D (thousands of euros);Total;616.053
Internal expenditure on R&D (thousands of euros);Main;401.754
Internal expenditure on R&D (thousands of euros);Secondary dwellings;86.676
Internal expenditure on R&D (thousands of euros);Tool;127.622
1) By nature of the expense: Current expenses;Total;574.245
1) By nature of the expense: Current expenses;Main;371.873
1) By nature of the expense: Current expenses;Secondary dwellings;81.601
1) By nature of the expense: Current expenses;Tool;120.772
1.1) Remuneration to researchers;Total;221.741
1.1) Remuneration to researchers;Main;145.148
1.1) Remuneration to researchers;Secondary dwellings;33.906
1.1) Remuneration to researchers;Tool;42.688
1.2) Remuneration to technicians and assistants;Total;102.464
1.2) Remuneration to technicians and assistants;Main;53.306
1.2) Remuneration to technicians and assistants;Secondary dwellings;17.155
1.2) Remuneration to technicians and assistants;Tool;32.002
1.3) Other current expenses;Total;250.041
1.3) Other current expenses;Main;173.419
1.3) Other current expenses;Secondary dwellings;30.540
1.3) Other current expenses;Tool;46.082
2) By nature of the expense: Capital expenses;Total;41.808
2) By nature of the expense: Capital expenses;Main;29.882
2) By nature of the expense: Capital expenses;Secondary dwellings;5.075
2) By nature of the expense: Capital expenses;Tool;6.851
2.1) Land and buildings;Total;5.359
2.1) Land and buildings;Main;3.592
2.1) Land and buildings;Secondary dwellings;486
2.1) Land and buildings;Tool;1.281
2.2) Equipment and instruments;Total;29.489
2.2) Equipment and instruments;Main;20.787
2.2) Equipment and instruments;Secondary dwellings;4.073
2.2) Equipment and instruments;Tool;4.630
2.3) Acquisition of specific R+D software;Total;2.306
2.3) Acquisition of specific R+D software;Main;1.549
2.3) Acquisition of specific R+D software;Secondary dwellings;139
2.3) Acquisition of specific R+D software;Tool;618
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;4.654
2.4) Otros productos de propiedad intelectual específicos para I+D;Main;3.955
2.4) Otros productos de propiedad intelectual específicos para I+D;Secondary dwellings;377
2.4) Otros productos de propiedad intelectual específicos para I+D;Tool;322
1) By origin of the funds: National funds;Total;511.960
1) By origin of the funds: National funds;Main;311.167
1) By origin of the funds: National funds;Secondary dwellings;76.048
1) By origin of the funds: National funds;Tool;124.744
1.1) Own funds;Total;382.335
1.1) Own funds;Main;232.410
1.1) Own funds;Secondary dwellings;47.954
1.1) Own funds;Tool;101.970
1.2) From companies;Total;45.024
1.2) From companies;Main;25.073
1.2) From companies;Secondary dwellings;10.783
1.2) From companies;Tool;9.168
1.3) Public Administration funds;Total;72.387
1.3) Public Administration funds;Main;45.317
1.3) Public Administration funds;Secondary dwellings;16.642
1.3) Public Administration funds;Tool;10.428
1.4) From Universities;Total;363
1.4) From Universities;Main;363
1.4) From Universities;Secondary dwellings;0
1.4) From Universities;Tool;.
1.5) From non profit private institutions;Total;11.851
1.5) From non profit private institutions;Main;8.005
1.5) From non profit private institutions;Secondary dwellings;669
1.5) From non profit private institutions;Tool;3.178
1) By origin of the funds: Foreign funds;Total;104.093
1) By origin of the funds: Foreign funds;Main;90.587
1) By origin of the funds: Foreign funds;Secondary dwellings;10.628
1) By origin of the funds: Foreign funds;Tool;2.879
2.1) From EU programmes;Total;21.825
2.1) From EU programmes;Main;13.669
2.1) From EU programmes;Secondary dwellings;5.814
2.1) From EU programmes;Tool;2.342
2.2) Other foreign funds;Total;82.269
2.2) Other foreign funds;Main;76.918
2.2) Other foreign funds;Secondary dwellings;4.813
2.2) Other foreign funds;Tool;537
Purchase of R&D services in biotechnology (thousands of euros);Total;144.342
Purchase of R&D services in biotechnology (thousands of euros);Main;91.533
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;26.448
Purchase of R&D services in biotechnology (thousands of euros);Tool;26.360
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;70.458
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;43.549
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;11.885
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;15.023
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;73.885
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;47.984
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;14.563
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;11.337
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;48
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;57
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;46
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;35
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;18
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;11
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;9
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Total;16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Main;17
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Secondary dwellings;18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Tool;11
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;40
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;43
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;26
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;47
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;39
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;17
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;24
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;16
% Companies that have requested biotechnology patents;Total;16
% Companies that have requested biotechnology patents;Main;24
% Companies that have requested biotechnology patents;Secondary dwellings;8
% Companies that have requested biotechnology patents;Tool;7
Number of patents requested;Total;633
Number of patents requested;Main;474
Number of patents requested;Secondary dwellings;71
Number of patents requested;Tool;88
% Companies with income of an international origin related to biotechnological activities;Total;24
% Companies with income of an international origin related to biotechnological activities;Main;32,7
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;15,5
% Companies with income of an international origin related to biotechnological activities;Tool;15,2
% Turnover representing income of an international origin related to biotechnological activities;Total;1,4
% Turnover representing income of an international origin related to biotechnological activities;Main;9
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;0,1
% Turnover representing income of an international origin related to biotechnological activities;Tool;2,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;57,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;35,5
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;37,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;77,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;42,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;64,5
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;62,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;22,4
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;82,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;91,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;80,2
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;74,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;16,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;7,1
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;.
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;25,6
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;1
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;1,1
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;19,6
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;0,1
% Income of an international origin related with activities according to the classification: Other;Total;0,3
% Income of an international origin related with activities according to the classification: Other;Main;0,6
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;0,2
% Income of an international origin related with activities according to the classification: Other;Tool;0